JNJ:
When JNJ was having some previous problems I used to spend three afternoons a week at their research headquarters in Raritan. In those days the problem was getting drugs approved at the FDA... trivial issues compared to what has been going on lately.
http://online.barrons.com/article/S....html?mod=BOL_hpp_emr_4#articleTabs_article=1
http://finance.yahoo.com/q/bc?t=5y&s=JNJ&l=off&z=l&q=l&c=&ql=1
Trade:
Sell the Jan '15 55 put and buy the Jan '15 50 put for a net credit of $95.
Yield = 95/405 = 23.4% in 747 days or 11.5% annualized
Prob = 95%
Expectation = .95(95) - .01(405) - .04(202) = 90.25 - 4.05 - 8.08 = 76.12
(note 95 is above the offer at closing but I think it will fill)
This is a very long term trade, as would be buying the stock, but with much higher return and much less risk... plus getting your payout up front which, given the long term nature of the trade, is not trivial.
This is NOT the typical in/out of monthly option traders. This is a completely different animal.
You cannot understand this trade without reading and understanding the reference above. IF the reference is right, and JNJ's troubles are behind it, this is a good trade... and much more 'conservative' than buying the stock.
To venture into JNJ land with 100 shares of stock would cost you $7,063. This costs just $405.
Also the calculations of probability and expectation have to be understood as descriptions of position of the trade relative to past history of stock price, not in the usual vernacular meaning of those terms.